Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Dominic Kaddu-Mulindwa, Vadim Lesan, Christian Berdel, Stephan Stilgenbauer, Moritz Bewarder, Lorenz Thurner, Mathias Witzens-Harig, Andreas Viardot, Martin Soekler, Ulrich Keller, Lorenz Truemper, Konstantinos Christofyllakis, Octavian Fleser, Joerg Thomas Bittenbring, Viola Poeschel, Gerhard Held & Philippe Jagoda. (2022) Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Leukemia & Lymphoma 63:2, pages 326-334.
Read now
Read now
Pernille Svendsen, Nitesh Shekhrajka, Kasper Lindblad Nielsen, Peter Vestergaard, Mette Østergaard Poulsen, Anders Krog Vistisen, Peter Svenssen Munksgaard, Marianne Tang Severinsen, Paw Jensen, Hans Erik Johnsen, Lasse Hjort Jakobsen, Martin Bøgsted, Jens Brøndum Frøkjær & Tarec Christoffer El-Galaly. (2017) R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients. Leukemia & Lymphoma 58:5, pages 1105-1113.
Read now
Read now
Ursa Brown-Glaberman & Alison T Stopeck. (2013) Impact of denosumab on bone mass in cancer patients. Clinical Pharmacology: Advances and Applications 5, pages 117-129.
Read now
Read now
Articles from other publishers (28)
Maria Cristina Pirosa, Fabiana Esposito, Giorgio Raia, Vito Chianca, Andrea Cozzi, Lorenzo Ruinelli, Luca Ceriani, Emanuele Zucca, Filippo Del Grande & Stefania Rizzo. (2023) CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival. La radiologia medica 128:12, pages 1497-1507.
Crossref
Crossref
Inna Y. Gong, Kelvin K. W. Chan, Lorraine L. Lipscombe, Matthew C. Cheung & Lee Mozessohn. (2023) Fracture risk among patients with cancer compared to individuals without cancer: a population-based study. British Journal of Cancer 129:4, pages 665-671.
Crossref
Crossref
Fabiana Esposito, Maria Rosaria Pascale, Cristiano Tesei, Paola Elda Gigliotti, Alessandra Luciano, Cecilia Angeloni, Massimiliano Marinoni, Federico Meconi, Roberto Secchi, Alberto Patanè, Massimiliano Postorino, Maria Cantonetti & Guglielmo Manenti. (2023) Body Composition in Patients with Follicular Lymphoma: Asso-Ciations between Changes in Radiomic Parameters in Patients Treated with R-CHOP-like and R-B Regimens: LyRa 01F. Cancers 15:4, pages 999.
Crossref
Crossref
Toby A. Eyre, Paw Jensen, Stephen Booth & Tarec Christoffer El‐Galaly. (2022) Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures. British Journal of Haematology 198:3, pages 431-442.
Crossref
Crossref
Paw Jensen, Lasse Hjort JakobsenMartin BøgstedJoachim Baech, Simon Lykkeboe, Marianne Tang Severinsen, Peter Vestergaard & Tarec Christoffer El-Galaly. (2022) A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment. Blood Advances 6:8, pages 2549-2556.
Crossref
Crossref
Mahmoud M. Sobh, Mohamed Abdalbary, Sherouk Elnagar, Eman Nagy, Nehal Elshabrawy, Mostafa Abdelsalam, Kamyar Asadipooya & Amr El-Husseini. (2022) Secondary Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Medicine 11:9, pages 2382.
Crossref
Crossref
Sergio Di Molfetta, Antonella Daniele, Chiara Gerardi, Eleonora Allocati, Carla Minoia, Giacomo Loseto, Francesco Giorgino, Attilio Guarini & Vitaliana De Sanctis. (2022) Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi. Cancers 14:6, pages 1439.
Crossref
Crossref
Li-Wen Huang, Dong Sun, Thomas M. Link, Thomas Lang, Weiyun Ai, Lawrence D. Kaplan, Michael A. Steinman & Charalambos Andreadis. (2021) High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas. Supportive Care in Cancer 29:9, pages 5399-5408.
Crossref
Crossref
J. Bodden, D. Sun, G. B. Joseph, L.-W. Huang, C. Andreadis, M. Hughes-Fulford, T. F. Lang & T. M. Link. (2020) Identification of non-Hodgkin lymphoma patients at risk for treatment-related vertebral density loss and fractures. Osteoporosis International 32:2, pages 281-291.
Crossref
Crossref
Stephen Booth, Hannah PlaschkesAmy A. KirkwoodAdam Gibb, Patrick HorganClaire HighamJoanna M. OladipoJoe BrowningUsman KhanBing TseuLucia ChenJohn WillanJulia WolfArief GunawanPaul FieldsTim Ebsworth, Robert Lown, Dominic Gordon-WalkerNimish ShahKim M. Linton, Graham P. CollinsJaimal KothariCatherine HildyardToby A. Eyre. (2020) Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma. Blood Advances 4:18, pages 4337-4346.
Crossref
Crossref
Peter Johansson, Hallgerdur Lind Kristjansdottir, Helena Johansson, Ana Jakir, Dan Mellström & Catharina Lewerin. (2020) Increased Risk of Hip Fracture in Patients with Lymphoma, a Swedish Population Study of 37,236 Lymphoma Patients. Calcified Tissue International 106:6, pages 591-598.
Crossref
Crossref
Konstantinos Anargyrou, Despina Fotiou, Theodoros P. Vassilakopoulos, Dimitrios Christoulas, Polyzois Makras, Maria DimouIoannis Ntanasis-Stathopoulos, Stavroula Masouridou, Maria K. Angelopoulou, Athanasios Papatheodorou, Konstantinos Tsionos, Panayiotis PanayiotidisMeletios A. Dimopoulos & Evangelos Terpos. (2019) Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study. HemaSphere 3:6, pages e303.
Crossref
Crossref
Sofia Vaz, Sharjeel Usmani, Gopinath Gnanasegaran & Tim Van den Wyngaert. (2019) Molecular imaging of bone metastases using bone targeted tracers. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 63:2.
Crossref
Crossref
Christina V. OlesonChristina V. Oleson. 2017. Osteoporosis Rehabilitation. Osteoporosis Rehabilitation
349
389
.
Chu-Chyn Ou, Yi-Min Hsiao, Ting-Yi Hou, Ming-Fang Wu & Jiunn-Liang Ko. (2015) Fungal immunomodulatory proteins alleviate docetaxel-induced adverse effects. Journal of Functional Foods 19, pages 451-463.
Crossref
Crossref
Judith Gebauer, Eva-Maria Fick, Annika Waldmann, Thorsten Langer, Ilonka Kreitschmann-Andermahr, Hendrik Lehnert, Alexander Katalinic & Georg Brabant. (2015) Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany. European Journal of Endocrinology 173:2, pages 139-148.
Crossref
Crossref
Carlo Messina, David Christie, Emanuele Zucca, Mary Gospodarowicz & Andrés J.M. Ferreri. (2015) Primary and secondary bone lymphomas. Cancer Treatment Reviews 41:3, pages 235-246.
Crossref
Crossref
Jennifer H. Jordan, Soe Soe Thwin, Timothy L. Lash, Diana S. M. Buist, Terry S. Field, Reina Haque, Pamala A. Pawloski, Hans V. Petersen, Marianne N. Prout, Virginia P. Quinn, Marianne Ulcickas Yood, Rebecca A. Silliman & Ann M. Geiger. (2014) Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Research and Treatment 146:2, pages 401-409.
Crossref
Crossref
M.A. Thompson, J.R. Westin & F.B. Hagemeister. (2014) Bone mineral density screening should be routine in lymphoma patients. Annals of Oncology 25:4, pages 913-914.
Crossref
Crossref
J. Paccou, L. Merlusca, I. Henry-Desailly, A. Parcelier, B. Gruson, B. Royer, A. Charbonnier, D. Ursu, R. Desailloud, R. Garidi, S. Kamel, H. Sevestre, J.P. Marolleau, P. Fardellone & G. Damaj. (2014) Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Annals of Oncology 25:2, pages 481-486.
Crossref
Crossref
S. Govi, D. Christie, C. Messina, M. Bruno Ventre, E.A. Gracia Medina, D. Porter, J. Radford, D. Seog Heo, Y. Park, G. Martinelli, E. Taylor, H. Lucraft, V. Ballova, E. Zucca, M. Gospodarowicz & A.J.M. Ferreri. (2014) The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone. Annals of Oncology 25:1, pages 176-181.
Crossref
Crossref
Kathy L. Schulman, Karina Berenson, Ya-Chen (Tina) Shih, Kathleen A. Foley, Arijit Ganguli, Jonas de Souza, Nicholas A. Yaghmour & Alex Shteynshlyuger. (2013) A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group. Value in Health 16:4, pages 655-669.
Crossref
Crossref
Jason R. Westin, Michael A. Thompson, Vince D. Cataldo, Luis E. Fayad, Nathan Fowler, Michelle A. Fanale, Saatva Neelapu, Felipe Samaniego, Jorge Romaguera, Jatin Shah, Peter McLaughlin, Barbara Pro, Larry W. Kwak, Perpetua Sanjorjo, William A. Murphy, Camillo Jimenez, Bela Toth, Wenli Dong & Fredrick B. Hagemeister. (2013) Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial. Clinical Lymphoma Myeloma and Leukemia 13:2, pages 99-105.
Crossref
Crossref
Mimi I. Hu, Huifang Lu & Robert F. Gagel. (2010) Cancer Therapies and Bone Health. Current Rheumatology Reports 12:3, pages 177-185.
Crossref
Crossref
Nancy N. Baxter, Sara B. Durham, Kelly-Anne Phillips, Elizabeth B. Habermann & Beth A. Virning. (2009) Risk of Dementia in Older Breast Cancer Survivors: A Population-Based Cohort Study of the Association with Adjuvant Chemotherapy. Journal of the American Geriatrics Society 57:3, pages 403-411.
Crossref
Crossref
Supriya Mohile, Nail Nagovskiy & Lodovico Balducci. 2009. Geriatric Oncology. Geriatric Oncology
201
261
.
Juliette Allport. (2008) Incidence and prevalence of medication-induced osteoporosis: evidence-based review. Current Opinion in Rheumatology 20:4, pages 435-441.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:3.
Crossref
Crossref